Pasar al contenido principal

DESEQUILIBRIO NUTRICIONAL E INDUCCION DE MUERTE CELULAR EN CANCER: ASPECTOS FUNDAMENTALES Y TRANSLACIONALES DE LA GLUTAMOPTOSIS

PGC2018-096244-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia

  • Nguyen, Tra Ly
  • Nokin, Marie-Julie
  • Terés, Silvia
  • Tomé, Mercedes
  • Bodineau, Clément
  • Galmar, Oriane
  • Pasquet, Jean-Max
  • Rousseau, Benoit
  • Liempd, Sebastian van
  • Falcón-Pérez, Juan M.
  • Richard, Elodie
  • Muzotte, Elodie
  • Rezvani, Hamid-Reza
  • Priault, Muriel
  • Bouchecareilh, Marlon
  • Redonnet-Vernhet, Isabelle
  • Calvo, Julien
  • Uzan, Benjamin
  • Pflumio, Françoise
  • Fuentes, Patricia
  • Toribio, María Luisa
  • Khatib, Abdel-Majid
  • Soubeyran, Pierre
  • Murdoch, Piedad del S.
  • Durán, Raúl V.
The cellular receptor Notch1 is a central regulator of T-cell development, and as a consequence, Notch1 pathway appears upregulated in > 65% of the cases of T-cell acute lymphoblastic leukemia (T-ALL). However, strategies targeting Notch1 signaling render only modest results in the clinic due to treatment resistance and severe side effects. While many investigations reported the different aspects of tumor cell growth and leukemia progression controlled by Notch1, less is known regarding the modifications of cellular metabolism induced by Notch1 upregulation in T-ALL. Previously, glutaminolysis inhibition has been proposed to synergize with anti-Notch therapies in T-ALL models. In this work, we report that Notch1 upregulation in T-ALL induced a change in the metabolism of the important amino acid glutamine, preventing glutamine synthesis through the downregulation of glutamine synthetase (GS). Downregulation of GS was responsible for glutamine addiction in Notch1-driven T-ALL both in vitro and in vivo. Our results also confirmed an increase in glutaminolysis mediated by Notch1. Increased glutaminolysis resulted in the activation of the mammalian target of rapamycin complex 1 (mTORC1) pathway, a central controller of cell growth. However, glutaminolysis did not play any role in Notch1-induced glutamine addiction. Finally, the combined treatment targeting mTORC1 and limiting glutamine availability had a synergistic effect to induce apoptosis and to prevent Notch1-driven leukemia progression. Our results placed glutamine limitation and mTORC1 inhibition as a potential therapy against Notch1-driven leukemia., This work was supported by funds from the followinginstitutions: Agencia Estatal de Investigacion/Euro-pean Regional Development Fund, European Union(PGC2018-096244-B-I00, SAF2016-75442-R), Ministryof Science, Innovation and Universities of Spain,Spanish National Research Council—CSIC, InstitutNational de la Sante et de la Recherche Medicale—INSERM, Ligue Contre le Cancer—Gironde, Univer-site de Bordeaux, Fondation pour la Recherche Medi-cale, the Conseil Regional d’Aquitaine, SIRIC-BRIO,Fondation ARC and Institut Europeen de Chimie etBiologie. MJN was supported by a bourse d’excellencede la Federation Wallonie-Bruxelles (WBI) and a post-doctoral fellowship from Fondation ARC. We thankVincent Pitard (Flow Cytometry Platform, Universitede Bordeaux, France) for technical assistance in flowcytometry experiments. We thank Diana Cabrera(Metabolomics Platform, CIC bioGUNE, Spain) fortechnical assistance in metabolomics analysis
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis

  • Bodineau, Clément
  • Tomé, Mercedes
  • Courtois, Sarah
  • Costa, Ana S. H.
  • Sciacovelli, Marco
  • Rousseau, Benoit
  • Richard, Elodie
  • Vacher, Pierre
  • Parejo-Pérez, Carlos
  • Bessède, Emilie
  • Varon, Christine
  • Soubeyran, Pierre
  • Frezza, Christian
  • Murdoch, Piedad del S.
  • Villar, Victor H.
  • Durán, Raúl V.
Glutamoptosis is the induction of apoptotic cell death as a consequence of the aberrant activation of glutaminolysis and mTORC1 signaling during nutritional imbalance in proliferating cells. The role of the bioenergetic sensor AMPK during glutamoptosis is not defined yet. Here, we show that AMPK reactivation blocks both the glutamine-dependent activation of mTORC1 and glutamoptosis in vitro and in vivo. We also show that glutamine is used for asparagine synthesis and the GABA shunt to produce ATP and to inhibit AMPK, independently of glutaminolysis. Overall, our results indicate that glutamine metabolism is connected with mTORC1 activation through two parallel pathways: an acute alpha-ketoglutarate-dependent pathway; and a secondary ATP/AMPK-dependent pathway. This dual metabolic connection between glutamine and mTORC1 must be considered for the future design of therapeutic strategies to prevent cell growth in diseases such as cancer., This work was supported by funds from the following institutions: Agencia Estatal de Investigación/European Regional Development Fund, European Union (PGC2018-096244- B-I00, SAF2016-75442-R), Ministry of Science, Innovation and Universities of Spain, Spanish National Research Council—CSIC, Institut National de la Santé et de la Recherche Médicale —INSERM, Université de Bordeaux, Fondation pour la Recherche Médicale, the Conseil Régional d’Aquitaine, SIRIC-BRIO, Fondation ARC, and Institut Européen de Chimie et Biologie. C.B. was recipient of fellowships from the Minister of Higher Education, Research and Innovation (France) and the Fondation ARC (France).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia

  • Nguyen, Tra Ly
  • Nokin, Marie-Julie
  • Terés, Silvia
  • Tomé, Mercedes
  • Bodineau, Clément
  • Galmar, Oriane
  • Pasquet, Jean-Max
  • Rousseau, Benoit
  • Liempd, Sebastian van
  • Falcón-Pérez, Juan M.
  • Richard, Elodie
  • Muzotte, Elodie
  • Rezvani, Hamid-Reza
  • Priault, Muriel
  • Bouchecareilh, Marlon
  • Redonnet-Vernhet, Isabelle
  • Calvo, Julien
  • Uzan, Benjamin
  • Pflumio, Françoise
  • Fuentes, Patricia
  • Toribio, María Luisa
  • Khatib, Abdel-Majid
  • Soubeyran, Pierre
  • Murdoch, Piedad del S.
  • Durán, Raúl V.
The cellular receptor Notch1 is a central regulator of T-cell development, and as a consequence, Notch1 pathway appears upregulated in > 65% of the cases of T-cell acute lymphoblastic leukemia (T-ALL). However, strategies targeting Notch1 signaling render only modest results in the clinic due to treatment resistance and severe side effects. While many investigations reported the different aspects of tumor cell growth and leukemia progression controlled by Notch1, less is known regarding the modifications of cellular metabolism induced by Notch1 upregulation in T-ALL. Previously, glutaminolysis inhibition has been proposed to synergize with anti-Notch therapies in T-ALL models. In this work, we report that Notch1 upregulation in T-ALL induced a change in the metabolism of the important amino acid glutamine, preventing glutamine synthesis through the downregulation of glutamine synthetase (GS). Downregulation of GS was responsible for glutamine addiction in Notch1-driven T-ALL both in vitro and in vivo. Our results also confirmed an increase in glutaminolysis mediated by Notch1. Increased glutaminolysis resulted in the activation of the mammalian target of rapamycin complex 1 (mTORC1) pathway, a central controller of cell growth. However, glutaminolysis did not play any role in Notch1-induced glutamine addiction. Finally, the combined treatment targeting mTORC1 and limiting glutamine availability had a synergistic effect to induce apoptosis and to prevent Notch1-driven leukemia progression. Our results placed glutamine limitation and mTORC1 inhibition as a potential therapy against Notch1-driven leukemia., This work was supported by funds from the followinginstitutions: Agencia Estatal de Investigacion/Euro-pean Regional Development Fund, European Union(PGC2018-096244-B-I00, SAF2016-75442-R), Ministryof Science, Innovation and Universities of Spain,Spanish National Research Council—CSIC, InstitutNational de la Sante et de la Recherche Medicale—INSERM, Ligue Contre le Cancer—Gironde, Univer-site de Bordeaux, Fondation pour la Recherche Medi-cale, the Conseil Regional d’Aquitaine, SIRIC-BRIO,Fondation ARC and Institut Europeen de Chimie etBiologie. MJN was supported by a bourse d’excellencede la Federation Wallonie-Bruxelles (WBI) and a post-doctoral fellowship from Fondation ARC. We thankVincent Pitard (Flow Cytometry Platform, Universitede Bordeaux, France) for technical assistance in flowcytometry experiments. We thank Diana Cabrera(Metabolomics Platform, CIC bioGUNE, Spain) fortechnical assistance in metabolomics analysis
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Method for Unsupervised Semi-Quantification of Inmunohistochemical Staining with Beta Divergences

  • Sarmiento, Auxiliadora
  • Durán-Díaz, Iván
  • Fondón, Irene
  • Tomé, Mercedes
  • Bodineau, Clément
  • Durán, Raúl V.
In many research laboratories, it is essential to determine the relative expression levels of some proteins of interest in tissue samples. The semi-quantitative scoring of a set of images consists of establishing a scale of scores ranging from zero or one to a maximum number set by the researcher and assigning a score to each image that should represent some predefined characteristic of the IHC staining, such as its intensity. However, manual scoring depends on the judgment of an observer and therefore exposes the assessment to a certain level of bias. In this work, we present a fully automatic and unsupervised method for comparative biomarker quantification in histopathological brightfield images. The method relies on a color separation method that discriminates between two chromogens expressed as brown and blue colors robustly, independent of color variation or biomarker expression level. For this purpose, we have adopted a two-stage stain separation approach in the optical density space. First, a preliminary separation is performed using a deconvolution method in which the color vectors of the stains are determined after an eigendecomposition of the data. Then, we adjust the separation using the non-negative matrix factorization method with beta divergences, initializing the algorithm with the matrices resulting from the previous step. After that, a feature vector of each image based on the intensity of the two chromogens is determined. Finally, the images are annotated using a systematically initialized k-means clustering algorithm with beta divergences. The method clearly defines the initial boundaries of the categories, although some flexibility is added. Experiments for the semi-quantitative scoring of images in five categories have been carried out by comparing the results with the scores of four expert researchers yielding accuracies that range between 76.60% and 94.58%. These results show that the proposed automatic scoring system, which is definable and reproducible, produces consistent results., This research was funded by the Ministerio de Economía, Industria y Competitividad (MINECO) of the Government of Spain, grant number TEC2017- 82807-P, by the European Regional Development Fund (ERDF), European Union grant number PGC2018-096244-B-I00, SAF2016-75442-R and by FEDER/Junta de Andalucía-Consejería de Economía y Conocimiento grant number US-1264994.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Manganese is a physiologically relevant TORC1 activator in yeast and mammals

  • Nicastro, Raffaele
  • Gaillard, Hélène
  • Zarzuela, Laura
  • Péli-Gulli, Marie-Pierre
  • Fernández-García, Elisabet
  • Tomé, Mercedes
  • García-Rodríguez, Néstor
  • Durán, Raúl V.
  • Virgilio, Claudio de
  • Wellinger, Ralf Erik
The essential biometal manganese (Mn) serves as a cofactor for several enzymes that are crucial for the prevention of human diseases. Whether intracellular Mn levels may be sensed and modulate intracellular signaling events has so far remained largely unexplored. The highly conserved target of rapamycin complex 1 (TORC1, mTORC1 in mammals) protein kinase requires divalent metal cofactors such as magnesium (Mg2+) to phosphorylate effectors as part of a homeostatic process that coordinates cell growth and metabolism with nutrient and/or growth factor availability. Here, our genetic approaches reveal that TORC1 activity is stimulated in vivo by elevated cytoplasmic Mn levels, which can be induced by loss of the Golgi-resident Mn2+ transporter Pmr1 and which depend on the natural resistance-associated macrophage protein (NRAMP) metal ion transporters Smf1 and Smf2. Accordingly, genetic interventions that increase cytoplasmic Mn2+ levels antagonize the effects of rapamycin in triggering autophagy, mitophagy, and Rtg1-Rtg3-dependent mitochondrion-to-nucleus retrograde signaling. Surprisingly, our in vitro protein kinase assays uncovered that Mn2+ activates TORC1 substantially better than Mg2+, which is primarily due to its ability to lower the Km for ATP, thereby allowing more efficient ATP coordination in the catalytic cleft of TORC1. These findings, therefore, provide both a mechanism to explain our genetic observations in yeast and a rationale for how fluctuations in trace amounts of Mn can become physiologically relevant. Supporting this notion, TORC1 is also wired to feedback control mechanisms that impinge on Smf1 and Smf2. Finally, we also show that Mn2+-mediated control of TORC1 is evolutionarily conserved in mammals, which may prove relevant for our understanding of the role of Mn in human diseases., We thank María Díaz de la Loza and Benjamin Pillet for scientific illustration work, and V Albanèse, E de Nadal, V Goder, KD Hirschi, C Ungermann, and E Gottlieb for plasmids, yeast strains, and cell lines. Research was funded by grants from the University of Seville (2020/00001326), Junta de Andalucía/ European Union Regional Funds (P20-RT- 01220) and EMBO (STF-8685) to REW; the Swiss National Science Foundation (310030_166474/184671) to CDV; the Spanish Ministry of Science, Innovation and Universities (PGC2018-096244- B- I00) to RD. The author LZ was the recipient of a predoctoral grant from the Spanish Ministry of Science, Innovation and Universities (FPU19/04914).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glutamine, MTOR and autophagy: a multiconnection relationship

  • Bodineau, Clément
  • Tomé, Mercedes
  • Murdoch, Piedad del S.
  • Durán, Raúl V.
Cancer cells metabolize glutamine mostly through glutaminolysis, a metabolic pathway that activates MTORC1. The AMPK-MTORC1 signaling axis is a key regulator of cell growth and proliferation. Our recent investigation identified that the connection between glutamine and AMPK is not restricted to glutaminolysis. Rather, we demonstrated the crucial role of ASNS (asparagine synthetase (glutamine-hydrolyzing)) and the GABA shunt for the metabolic control of the AMPK-MTORC1 axis during glutamine sufficiency. Our results elucidated a metabolic network by which glutamine metabolism regulates the MTORC1-macroautophagy/autophagy pathway through two independent branches involving glutaminolysis and ASNS-GABA shunt. Abbreviations: αKG: alpha-ketoglutarate; AMPK: AMP-activated protein kinase; ASNS: asparagine synthetase (glutamine-hydrolyzing); GLUD/GDH: glutamate dehydrogenase; GLS: glutaminase; GOT1: glutamic-oxaloacetic transaminase 1; MTORC1: mechanistic target of rapamycin kinase complex 1; TCA: tricarboxylic acid., This work was supported by the Agencia Estatal de Investigación [PGC2018-096244- B-I00, SAF2016-75442-R];Ministry of Science, Innovation and Universities of Spain, Spanish National Research Council—CSIC;
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis

  • Cabré, Noemí
  • Luciano-Mateo, Fedra
  • Chapski, Douglas J.
  • Baiges-Gaya, Gerard
  • Fernández-Arroyo, Salvador
  • Hernández-Aguilera, Anna
  • Castañé, Helena
  • Rodríguez-Tomàs, Elisabet
  • París, Marta
  • Sabench, Fàtima
  • Castillo, Daniel del
  • Bas, Josep Maria del
  • Tomé, Mercedes
  • Bodineau, Clément
  • Sola-García, Alejandro
  • López-Miranda, José
  • Martín-Montalvo, Alejandro
  • Durán, Raúl V.
  • Vondriska, Thomas M.
  • Rosa-Garrido, Manuel
  • Camps, Jordi
  • Menéndez, Javier A.
  • Joven, Jorge
The surgically induced remission of liver disease represents a model to investigate the signalling processes that trigger the development of nonalcoholic steatohepatitis with the aim of identifying novel therapeutic targets. We recruited patients with severe obesity with or without nonalcoholic steatohepatitis and obtained liver and plasma samples before and after laparoscopic sleeve gastrectomy for immunoblotting, immunocytochemical, metabolomic, transcriptomic and epigenetic analyses. Functional studies were performed in HepG2 cells and primary hepatocytes. Surgery was associated with a decrease in the inflammatory response and revealed the role of mitogen-activated protein kinases. Nonalcoholic steatohepatitis was associated with an increased glutaminolysis-induced production of α-ketoglutarate and the hyperactivation of mammalian target of rapamycin complex 1. These changes were crucial for adenosine monophosphate-activated protein kinase/mammalian target of rapamycin-driven pathways that modulated hepatocyte survival by coordinating apoptosis and autophagy and affected methylation-related epigenomic remodelling enzymes. Hepatic transcriptome signatures and differentially methylated genomic regions distinguished patients with and without steatohepatitis. Our results suggest that the increased glutaminolysis-induced α-ketoglutarate production and the mammalian target of rapamycin complex 1 dysregulation play a crucial role in the inefficient adaptive responses leading to steatohepatitis in obesity., This study was funded by Instituto de Salud Carlos III, Madrid, Spain (Grants PI15/00285, PI18/00921, PI18/01590, and CPII/00023) co-funded by the European Regional Development Fund [FEDER], the Generalitat de Catalunya, Barcelona, Spain (SGR1227), Fundació La Marató de TV3, Barcelona, Spain (60/U/2016), and Ministry of Science, Innovation and Universities, Madrid, Spain (PGC2018-096244-B-I00).